Actiq DC

Actiq DC

An oral/transmucosal-“lollipop” delivery system developed to alleviate breakthrough pain in cancer patients.  It is also prescribed for off-label indications, including bone injuries, migraines, back pain, cluster headaches, neuropathy, arthritis, and other moderate to severe chronic, non-malignant pain.

The Actiq lollipop is available in 6 different dosage strengths and is indicated for management of breakthrough cancer pain in patients with malignancies who are already receiving opiates for pain control.